HSIC

SELL

Henry Schein, Inc.

Healthcare · Rank #406 · Analyzed Apr 20, 2026

$78.83

Current Price

$85.55

Intrinsic Value

+90.3%

Upside/Downside

1.5/10

Score

1.5/5

Quality

Analysis Summary

Valuation Consensus1/3 methods agree

Quality Score1.5/5.0

Framework RatingSELL

Price vs Intrinsic ValueUndervalued by 90.3%

Fair Value Range

Low$33.42

Base (IV)$85.55

High$150.04

Entry Points

Conservative$33.42

Moderate$59.49

Aggressive$85.55

Quality & Moat Breakdown

Return on Equity8.7% → 0/1.0

Debt LevelD/E 72 → 0/1.0

Revenue QualityGrowth 4.9%, margin Δ-1.2% +recovery → 1.0/1.0

Moat Strength1.0/5 → 0/1.0

Profit Margins3.0% → 0.5/1.0

Methodology

This analysis uses a unified valuation framework combining three methods — Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation — with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.